Wave Life Sciences Ltd. — Director's Dealing 2019

Aug 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2019-08-15

Reporting Person: TAKANASHI KEN (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-15	Share Option (right to buy)	$20.34	A	10500	Acquired	2024-08-15	Ordinary Shares (10500)	Direct

Footnotes

F1: The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2020 annual general meeting or August 15, 2020.